Sight Sciences Inc (NAS:SGHT)

$ 3.86 -0.16 (-3.98%) Market Cap: 194.54 Mil Enterprise Value: 119.32 Mil PE Ratio: 0 PB Ratio: 2.13 GF Score: 75/100

Q3 2024 Sight Sciences Inc Earnings Call Transcript
Nov 07, 2024

$4.68 (-8.24%)

Earnings
Q2 2024 Sight Sciences Inc Earnings Call Transcript
Aug 01, 2024

$7.42 (-4.63%)

Earnings
Q1 2024 Sight Sciences Inc Earnings Call Transcript
May 02, 2024

$5.61 (+0.36%)

Earnings
Q4 2023 Sight Sciences Inc Earnings Call Transcript
Mar 07, 2024

$4.6 (+0.66%)

Earnings
Q3 2023 Sight Sciences Inc Earnings Call Transcript
Nov 07, 2023

$2.1 (+22.09%)

Earnings
Sight Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Q2 2023 Sight Sciences Inc Earnings Call Transcript
Aug 03, 2023

$8.04 (+3.21%)

Earnings
Q1 2023 Sight Sciences Inc Earnings Call Transcript
May 04, 2023

$10.67 (+6.27%)

Earnings
Q4 2022 Sight Sciences Inc Earnings Call Transcript
Mar 13, 2023

$9.4 (+1.51%)

Earnings
Sight Sciences Inc at Citi Healthcare & Medtech Conference Transcript
Mar 01, 2023
Q2 2021 Sight Sciences Inc Earnings Call Transcript
Aug 12, 2021

$37.79 (+1.83%)

Earnings

Q4 2022 Sight Sciences Inc Earnings Call Transcript

Mar 13, 2023 / 08:30PM GMT

Release Date Price: $9.4 (+1.51%)

Transcript 10-K8-K

Operator

Hello and welcome to Sight Sciences' Fourth Quarter 2022 Earnings Results. (Operator Instructions)

I would now like to hand the conference over to Trip Taylor of Investor Relations. You may begin.

Philip Taylor

Gilmartin Group LLC - Associate

Thank you for participating in today's call. Presenting today are Sight Sciences Co-Founder and Chief Executive Officer, Paul Badawi; Interim Chief Financial Officer, Jim Rodberg; and Head of Corporate Strategy, Tom Huang. Earlier today, Sight Sciences released financial results for the 3 months and full year ended December 31, 2022. A copy of the press release is available on the company's website at investors.sightsciences.com.

I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements within the meaning of the federal securities laws. Those include statements related to Sight Sciences' anticipated financial performance and operating results, market opportunity, the future impact of supply chain disruptions, business strategy

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.